Alnylam Reports Q1 Net Profit As Product Revenue Surges; Stock Up 8% In Pre-Market
30/4 14:59
(RTTNews) - Alnylam Pharmaceuticals, Inc.(ALNY), an RNAi therapeutics company, on Thursday reported a net income for the first quarter of fiscal 2026, supported by a surge in revenue, driven by net product revenues....